Maggie McCue, MS, RD, is affiliated with Takeda Pharmaceuticals USA, Inc., in Lexington, Massachusetts. McCue has published research focused on Attention-Deficit/Hyperactivity Disorder (ADHD) within the contexts of child and adolescent psychiatry and the COVID-19 pandemic. Her work includes studies on caregiver experiences managing ADHD in youth during the pandemic and the experiences of adults with ADHD in 2021. McCue's publications appear in Psychiatrist.com journals.
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
